CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
lifesciencesreview
US
EUROPE
APAC
CANADA
  • US
    • US
    • EUROPE
    • APAC
    • CANADA
    • LATAM
  • Home
  • Contributors
  • News
  • Conferences
  • Newsletter
  • Whitepapers
  • Magazine
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

  • Home
  • News

Recommended picks

Atavistik Bio Enhances Atavistic's AMPS Platform through Collaboration with Plex Research

Atavistik Bio Enhances Atavistic's...

The Two Key Trends Of AI In Biotechnology

The Two Key Trends Of AI In...

Compound K', Is Fast Absorbing And Has A Higher Immune-Boosting Effect Than Ginseng

Compound K', Is Fast Absorbing And...

Informa Pharma Intelligence announces the launch of its Citeline Connect

Informa Pharma Intelligence announces...

How Does Biotechnology Help the World

How Does Biotechnology Help the World

Pharma and Biotech are Looking to Cloud and AI to Expediate Drug Discovery

Pharma and Biotech are Looking to...

Advantages of Biotech Partnership

Advantages of Biotech Partnership

How AI Enhances Biotech Operations

How AI Enhances Biotech Operations

Atavistik Bio Enhances Atavistic's AMPS Platform through Collaboration with Plex Research

Atavistik Bio Enhances Atavistic's...

The Two Key Trends Of AI In Biotechnology

The Two Key Trends Of AI In...

Compound K', Is Fast Absorbing And Has A Higher Immune-Boosting Effect Than Ginseng

Compound K', Is Fast Absorbing And...

Informa Pharma Intelligence announces the launch of its Citeline Connect

Informa Pharma Intelligence announces...

How Does Biotechnology Help the World

How Does Biotechnology Help the World

Pharma and Biotech are Looking to Cloud and AI to Expediate Drug Discovery

Pharma and Biotech are Looking to...

Advantages of Biotech Partnership

Advantages of Biotech Partnership

How AI Enhances Biotech Operations

How AI Enhances Biotech Operations

Industry Giants Say Covid-19 Offers A 'Significant Opportunity' To Fast-Track Cancer Eradication

Life Sciences Review | Tuesday, May 24, 2022
Tweet

The Bloomberg New Economic International Cancer Coalition aims to improve patient access to clinical trials worldwide and coordinate regulations that may accelerate cancer cures and post-pandemic prevention.


FREMONT, CA: Following the COVID-19 pandemic, 35 industry heavyweights from the oncology and biopharma industries, including Johnson & Johnson, Novartis, and others, have called for irreversible cancer treatment and delivery reforms. It comes from the Bloomberg New Economy International Cancer Coalition, which advocates "intentional implementation" of its proposals. Amgen, Bayer, the Dana-Farber Cancer Institute, Genentech, Johnson & Johnson, Johns Hopkins, Novartis, and the FDA's Oncology Center of Excellence are among the members of the collaboration formed in spring 2021. The organization was founded with the ambitious goal of enhancing patient access to clinical trials around the world and coordinating legislation that may speed up cancer therapies and prevention in the aftermath of a pandemic.


Patients ceased signing up for trials, and clinic visits were canceled when the pandemic became a reality in 2020. Clinical trials, which are the lifeblood of every pharmaceutical or biotech company, have had to pivot or shut down. 


Before the pandemic, decentralized clinical trials were one of the few methods to keep the research going, with Novartis and J&J quickly moving to mailed medicines and home health visits, among other strategies described by large businesses.


The Bloomberg consortium now claims that telemedicine and remote technology can provide better cancer care for underprivileged communities more than two years after COVID-19 was released. The group claims that clinical trial flexibility during the pandemic offered new opportunities to improve patient experience and demonstrated the potential of technology and global collaboration to improve participant access and diversity in a consensus paper published in Nature Medicine. Patient identification and enrollment, treatment and monitoring, and regulatory harmonization across patient-centric clinical trials—studies that prioritize patient needs at all stages—were identified as the top priority to concentrate on by the alliance. The authors believe that patient-centric treatment can be achieved by removing barriers to trial participation, using technologies like telemedicine, remote monitoring, and liquid biopsy, and collaborating internationally, including regulatory harmonization.


 


Weekly Brief

loading
Top 10 Biotech Startups in APAC - 2022
> <
  • Regulatory Services 2023

    Top Vendors

    Current Issue
  • Clinical Lab Equipment 2023

    Top Vendors

    Current Issue
  • Proteomics 2022

    Top Vendors

    Current Issue
  • Regulatory Services 2023

    Top Vendors

    Current Issue
  • Clinical Lab Equipment 2023

    Top Vendors

    Current Issue
  • Proteomics 2022

    Top Vendors

    Current Issue

Read Also

Multiomic Preclinical Models to Define the Mechanism of Action

Mitch Sanders, Chief Scientific Officer and EVP of the ProDevLab, at Alira Health

Developing Patient-Centric Precision Oncology Therapies: Begin With The End In Mind

Sanjay Konagurthu, Senior Director, PDS Global Science and Technology, Thermo Fisher Scientific

What the New EMA Draft "Guideline on Computerised Systems and Electronic Data" Means to Your Systems

Cathlin Shapiro, Director, Technology Quality Assurance, Parexel

Pharmaceutical Tablet Coating - Past, Present and Future

Steve Brown, Senior Director EU and APAC Global Manufacturing Science and Technology, Teva Pharmaceuticals [NYSE: TEVA]

Dynamic Commercial Aspects of Life Sciences

Jim Cooper, Director, Clinical Operations, Moderna

Achieving trial master file quality, timeliness and completeness

Susan K. Maue, Designation : Managing Director PharmaLex

Antibodies: The Building Blocks of Cures

John Armstrong, Head of Research; Head of BD; Global Strategic Programs; Global Straegic Marketing, Galderma

The Dynamic Commercial Aspects of Life Sciences

Jim Cooper, Director, Clinical Operations, Moderna
Loading...

Copyright © 2023 Life Sciences Review . All rights reserved. |  Subscribe |  About Us follow on linkedin

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/news/industry-giants-say-covid19-offers-a--significant-opportunity--to-fasttrack-cancer-eradication-nwid-799.html